PNC Financial Services Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74K | Buy |
511
+228
| +81% | +$2.12K | ﹤0.01% | 4156 |
|
|
2025
Q1 | $2.07K | Buy |
+283
| New | +$2.07K | ﹤0.01% | 4331 |
|
|
2024
Q3 | – | Sell |
-106
| Closed | -$725 | – | 4873 |
|
|
2024
Q2 | $725 | Sell |
106
-16
| -13% | -$109 | ﹤0.01% | 4481 |
|
|
2024
Q1 | $1.11K | Buy |
122
+111
| +1,009% | +$1.01K | ﹤0.01% | 4345 |
|
|
2023
Q4 | $49 | Buy |
+11
| New | +$49 | ﹤0.01% | 4566 |
|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$7K | – | 4652 |
|
|
2021
Q4 | $7K | Buy |
+1,000
| New | +$7K | ﹤0.01% | 3883 |
|
|
2018
Q3 | – | Sell |
-1,500
| Closed | -$10K | – | 4203 |
|
|
2018
Q2 | $10K | Buy |
+1,500
| New | +$10K | ﹤0.01% | 3687 |
|